Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | adenosine deaminase | 0.0556 | 0.681 | 1 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0556 | 0.681 | 0.5 |
Plasmodium falciparum | adenosine deaminase | 0.0556 | 0.681 | 1 |
Plasmodium vivax | adenosine deaminase, putative | 0.0556 | 0.681 | 1 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0556 | 0.681 | 1 |
Trypanosoma cruzi | adenosine monophosphate deaminase-like protein, putative | 0.0181 | 0.1905 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0375 | 0.4441 | 0.6426 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0556 | 0.681 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Mycobacterium ulcerans | adenosine deaminase | 0.0556 | 0.681 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Treponema pallidum | adenosine deaminase | 0.0556 | 0.681 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0556 | 0.681 | 0.5 |
Entamoeba histolytica | AMP deaminase, putative | 0.0181 | 0.1905 | 0.2798 |
Trypanosoma cruzi | AMP deaminase 2, putative | 0.0181 | 0.1905 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Leishmania major | adenine aminohydrolase | 0.0556 | 0.681 | 1 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.0556 | 0.681 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0179 | 0.0263 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0556 | 0.681 | 1 |
Entamoeba histolytica | AMP deaminase, putative | 0.0181 | 0.1905 | 0.2798 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0181 | 0.1905 | 0.2604 |
Trypanosoma cruzi | adenosine monophosphate deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Brugia malayi | Adenosine/AMP deaminase family protein | 0.0556 | 0.681 | 1 |
Schistosoma mansoni | adenosine deaminase-related | 0.0556 | 0.681 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0179 | 0.0263 |
Echinococcus multilocularis | adenosine deaminase | 0.0556 | 0.681 | 0.681 |
Loa Loa (eye worm) | AMP deaminase | 0.0181 | 0.1905 | 0.2604 |
Trypanosoma brucei | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Brugia malayi | adenosine monophosphate deaminase | 0.0181 | 0.1905 | 0.2798 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0556 | 0.681 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0375 | 0.4441 | 0.6426 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0556 | 0.681 | 1 |
Schistosoma mansoni | AMP deaminase | 0.0181 | 0.1905 | 0.2798 |
Echinococcus granulosus | AMP deaminase 2 | 0.0181 | 0.1905 | 0.2798 |
Schistosoma mansoni | adenosine deaminase | 0.0556 | 0.681 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0375 | 0.4441 | 0.6426 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Echinococcus multilocularis | AMP deaminase 2 | 0.0181 | 0.1905 | 0.1905 |
Trypanosoma brucei | adenosine monophosphate deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0556 | 0.681 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0556 | 0.681 | 1 |
Trypanosoma brucei | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Trypanosoma brucei | AMP deaminase, putative | 0.0181 | 0.1905 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0375 | 0.4441 | 0.6426 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 3.12 ug ml-1 | In vitro inhibition of MRSA growth. | ChEMBL. | No reference |
MIC (functional) | = 6.25 ug ml-1 | In vitro inhibition of P. multocida growth. | ChEMBL. | No reference |
MIC (functional) | = 25 ug ml-1 | In vitro inhibition of E. coli growth. | ChEMBL. | No reference |
MIC (functional) | = 25 ug ml-1 | In vitro inhibition of E. coli growth. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.